With few low-price alternatives available in the feminine-product aisle, sales of period products are falling as many women and girls find their budgets can’t cover all essentials.
Related Posts
H&M Shares Plunge on Worsening Outlook
Hennes & Mauritz’s shares fell 13% after it made a weak start to its third quarter and warned that its performance would be hurt by […]
Eli Lilly to Buy Morphic Holding for $3.2 Billion
Eli Lilly has agreed to buy biopharmaceutical company Morphic Holding for $3.2 billion in a deal that bolsters the drugmaker’s immunology pipeline.
TotalEnergies Boosts Presence in Germany With VSB Deal
TotalEnergies struck a deal to buy renewable-energy company VSB Group from Partners Group for $1.7 billion, expanding its presence in Germany.